HRT Financial’s Sharps Compliance Corp SMED Stock Holding History

HRT Financial’s Portfolio SMED Stock Details SMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-16,660	Closed	-$98K	–	4058
2022 Q1	$98K	Buy	+16,660	New	+$105K	﹤0.01%	2664

Other funds holding SMED

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

NIM

Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

SMH

Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

HRT Financial's SMED Position: Q2 2022 in Review

HRT Financial sold out of Sharps Compliance Corp (SMED) in Q2 2022, closing a stake of 16,660 shares — an estimated $98K sold.

HRT Financial first reported a position in SMED in Q1 2022 and held it in 1 quarter. The position peaked at $98K in Q1 2022. 67 funds tracked by Wall St. Rank hold SMED as of Q2 2022.

HRT Financial reported no remaining Sharps Compliance Corp position as of Q2 2022 after selling out during the quarter.
HRT Financial sold 16,660 Sharps Compliance Corp shares in Q2 2022, an estimated $98K.
HRT Financial first reported a position in Sharps Compliance Corp in Q1 2022 and held it in 1 quarter.
HRT Financial's Sharps Compliance Corp position peaked at $98K in Q1 2022.
67 funds tracked by Wall St. Rank held Sharps Compliance Corp as of Q2 2022.

Based on HRT Financial's 13F filing for Q2 2022, filed 12 Aug 2022.